GLP-1 and Diabetes Management: How Ozempic and Mounjaro Changed Type 2 Diabetes Treatment

May 24, 2026

GLP-1 and Diabetes Management: How Ozempic and Mounjaro Changed Type 2 Diabetes Treatment

By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante

Key Takeaways

GLP-1 receptor agonists are now considered first-line therapy for type 2 diabetes in patients who also have cardiovascular disease, chronic kidney disease, or obesity. They've moved from "second-line add-on" to "give this first."
Semaglutide reduces HbA1c by 1.5-2.0% on average — comparable to insulin but with weight loss instead of weight gain, and lower hypoglycemia risk.
Tirzepatide (Mounjaro) is the most effective blood sugar-lowering medication currently available, reducing HbA1c by up to 2.4% in clinical trials.
GLP-1 doesn't just lower blood sugar — it addresses the root cause of type 2 diabetes: insulin resistance driven by excess adiposity, chronic inflammation, and metabolic dysfunction.

How GLP-1 Works in Diabetes

Glucose-Dependent Insulin Secretion

GLP-1 stimulates insulin release from pancreatic beta cells — BUT only when blood glucose is elevated. When glucose normalizes, the insulin stimulation stops.
This glucose-dependent mechanism means GLP-1 has a very low risk of hypoglycemia compared to sulfonylureas and insulin, which stimulate insulin regardless of blood glucose level.
This is particularly important for patients managing diabetes while fasting, exercising, or on irregular meal schedules.

Glucagon Suppression

In type 2 diabetes, glucagon (the hormone that raises blood sugar) is inappropriately elevated. The liver receives a signal to produce glucose even when blood sugar is already high.
GLP-1 suppresses this inappropriate glucagon secretion → less hepatic glucose output → lower fasting blood sugar.

Weight Loss

70-90% of type 2 diabetes patients are overweight or obese. Excess fat tissue causes insulin resistance — the fundamental defect in type 2 diabetes.
Losing 10-15% body weight can put type 2 diabetes into remission in many patients. GLP-1 typically achieves 15-20% weight loss.
This is why GLP-1 is called a "disease-modifying" treatment: it doesn't just lower blood sugar numbers — it addresses the underlying metabolic dysfunction.

Cardiovascular and Kidney Benefits

SUSTAIN-6 and SELECT trials: Semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20-26%.
FLOW trial: Semaglutide reduced kidney disease progression by 24% in patients with CKD and diabetes.
Blood pressure: Typical reduction of 2-5 mmHg systolic — meaningful for long-term cardiovascular risk.
Lipids: Reduces triglycerides, improves HDL. Modest LDL reduction.

Nutritional Management on GLP-1 for Diabetes

Hypoglycemia Prevention

If you're on GLP-1 PLUS a sulfonylurea (glimepiride, glipizide) or insulin, hypoglycemia risk increases.
Work with your prescriber to reduce sulfonylurea or insulin doses when starting GLP-1. Many patients can eventually stop these medications entirely.
Always carry fast-acting glucose (glucose tablets or juice) until medication adjustments stabilize.

Protein Prioritization

Protein has minimal impact on blood sugar compared to carbohydrates.
Prioritizing protein at each meal: stabilizes blood sugar, preserves muscle mass during weight loss, and keeps you fuller longer.
Target: 25-30g protein per meal minimum. Start each meal by eating protein first, then vegetables, then carbohydrates.

Carbohydrate Quality

You don't need to eliminate carbs, but choosing complex carbohydrates (sweet potato, brown rice, quinoa, oats) over simple carbohydrates (white bread, pasta, sugary foods) dramatically improves blood sugar stability.
Pairing carbohydrates with protein and fat slows absorption → smaller blood sugar spikes.

🛒 Diabetes + GLP-1 Nutrition

Whey Protein — Whey protein has been shown in clinical studies to lower post-meal blood glucose when consumed before or with a carbohydrate-containing meal. The insulin response to whey is rapid and glucose-dependent — it enhances your own body's insulin action. One scoop before meals or as a snack stabilizes blood sugar while preserving muscle.
Daily Vitamin — Chromium enhances insulin sensitivity. Magnesium is required for insulin receptor function (40-60% of diabetics are magnesium deficient). B vitamins support energy metabolism. Vitamin D improves beta cell function. All critical for diabetes management and commonly depleted on GLP-1.
Digestive Enzymes — Improved digestion means more predictable nutrient absorption, which means more predictable blood sugar responses. For diabetes patients, predictability is everything — knowing that your meals will be digested consistently helps with insulin dosing and carbohydrate counting.

Medical Disclaimer: This article is for educational purposes only. Do not adjust diabetes medications without consulting your prescriber. Hypoglycemia can be dangerous. Monitor blood sugar more frequently when starting or adjusting GLP-1 doses. Dr. Adegbola is the founder of Casa de Sante.

Back to blog

Keto. Paleo. No Digestive Triggers. Shop Now

No onion, no garlic – no pain. No gluten, no lactose – no bloat. Low FODMAP certified.

Stop worrying about what you can't eat and start enjoying what you can. No bloat, no pain, no problem.

Our gut friendly keto, paleo and low FODMAP certified products are gluten-free, lactose-free, soy free, no additives, preservatives or fillers and all natural for clean nutrition. Try them today and feel the difference!